MSN Laboratories Tech Stack

Research-backed pharma manufacturer with 25 plants across India and USA

Pharmaceutical Manufacturing Hyderabad, Telangana State 10,001+ employees Privately Held

MSN Laboratories operates a vertically integrated pharmaceutical business with 25 manufacturing facilities (17 API, 8 finished-dosage) and an in-house R&D center. The company runs SAP for ERP alongside specialized lab instruments (HPLC, UPLC, SDS-PAGE) and BI tools (Power BI), but projects reveal active friction around regulatory processes, dossier quality, and cross-functional launch coordination—typical pain points for scaled generics manufacturers navigating global compliance.

Tech Stack 12 technologies

Core StackActive Directory SAP QuickBooks Power Query Power BI CRM Tally Zoho HPLC UPLC SDS-PAGE

What MSN Laboratories Is Building

◆Challenges

Improving dossier quality
Enhancing regulatory processes
Maintaining inspection readiness
Managing qc budget
Compliance with gmp and gxp
Regulatory audit readiness
High availability of critical systems
Expanding presence in polish market
Managing distributed sales team
Cross-functional launch synchronization

▲Active Projects

New product registrations
Post-marketing activities
Regulatory strategy execution
Method transfer processes
Oos investigation process
Capa implementation
Compliance projects
Launch tracker sheet maintenance
Sap sku code creation
Regulatory green light verification

Hiring Activity

Accelerating25 roles · 25 in 30d

Department

Sales

Manufacturing

Legal

Ops

Quality

Executive

Finance

Seniority

Manager

Senior

Mid

Junior

Lead

Company intelligence

Find more companies like MSN Laboratories by tech stack, pain points and active projects

Get started free

About MSN Laboratories

MSN Laboratories is a research-based pharmaceutical manufacturer headquartered in Hyderabad, India, operating 25 manufacturing plants in India and the USA. The company manufactures active pharmaceutical ingredients (APIs) and finished-dosage formulations across 35+ therapeutic areas including oncology, cardiology, CNS, and diabetes. The product portfolio spans 500+ APIs and 400+ finished dosages. MSN operates an integrated R&D center, has filed 900+ patent applications, and serves over 40 million patients across 100+ countries. The organization employs over 15,000 professionals and holds the top global position in active US DMF filings. Current hiring spans sales, manufacturing, quality, and regulatory functions, with regional expansion into Ghana, Brazil, Costa Rica, and the Dominican Republic.

HeadquartersHyderabad, Telangana State

Company Size10,001+ employees

Hiring MarketsGhana, Brazil, India, Costa Rica, Dominican Republic

Frequently Asked Questions

What is MSN Laboratories' manufacturing footprint?

MSN operates 25 state-of-the-art facilities: 17 API manufacturing plants and 8 finished-dosage facilities, located in India and the USA. An integrated R&D center supports both API and finished-dosage research.

How many countries does MSN Laboratories serve?

MSN serves over 100 countries and has earned the trust of more than 40 million patients globally. The company is actively hiring in Ghana, Brazil, India, Costa Rica, and the Dominican Republic.

What tech stack does MSN Laboratories use?

Primary systems: SAP (ERP), Active Directory, CRM, Power BI (analytics), and accounting tools (Tally, QuickBooks). Lab operations rely on HPLC, UPLC, and SDS-PAGE instruments for quality control and R&D.

Similar Companies in Pharmaceutical Manufacturing

Other companies in the same industry, closest in size

Takeda

Pharmaceutical Manufacturing

How this profile is built

MSN Laboratories's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.